Jaundice, Neonatal Clinical Trial
Official title:
Comparison of Phototherapy Using Neolight Skylife Versus Standardized Phototherapy for Hyperbilirubinemia in Newborns
Verified date | May 2021 |
Source | HonorHealth Research Institute |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Phototherapy has served as a primary treatment for hyperbilirubinemia in newborn populations. The light emitted through phototherapy interacts with bilirubin at the skin level to transform it into water-soluble products eliminated in urine and stool. Efficacy of phototherapy relies on the irradiance dispensed at the skin level by the treatment and on the surface area of skin exposed. The purpose of this Investigator-initiated, prospective, two-arm, randomized control investigation is to compare the effect of a novel, newly available, FDA cleared, phototherapy device (Neolight Skylife) with the standard phototherapy treatments used in HonorHealth newborn nurseries (Natus-Neo Blue Blanket and GE Bili Soft Blanket) on healthy, newborns ≥ 35 weeks + 0 days Gestational Age (GA) at the time of birth in the treatment of hyperbilirubinemia. We hypothesize that the unconjugated bilirubin level will be comparably reduced across each treatment arm from baseline to 12 and 24 hour intervals.
Status | Completed |
Enrollment | 72 |
Est. completion date | July 15, 2020 |
Est. primary completion date | January 15, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A to 7 Minutes |
Eligibility | Inclusion Criteria: 1. Provision of at least one parent/legal guardian's signed and dated informed consent form 2. Stated willingness to comply with all study procedures and availability for the duration of the study 3. Infants born after 35 weeks and 0 days of gestation 4. Infants who developed significant hyperbilirubinemia Infants who developed significant hyperbilirubinemia per BiliToolTM plot requiring phototherapy as determined by the attending neonatologist utilizing the American Academy of Pediatrics' 1. Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation (Bhutani Nomogram) 2. Guidelines for Phototherapy in Hospitalized Infants of 35 or More Weeks Gestation Exclusion Criteria: Participants will be screened on the following exclusion criteria at the time of enrollment: - Perinatal asphyxia (Apgar score <4 at 1 minute or <7 at 5 minutes) - Respiratory distress - Exchange transfusion - Major congenital malformations As identified throughout the course of the investigation, additional exclusion criteria include: - Direct-reacting component of bilirubin >2 mg/dL - Glucose-6-phosphate deficiency - ABO incompatibility - Evidence of hemolysis - Evidence of sepsis - Rhesus hemolytic disease - Pyruvate kinase deficiency - Severe dehydration |
Country | Name | City | State |
---|---|---|---|
United States | HonorHealth Scottsdale Osborn Medical Center | Scottsdale | Arizona |
United States | HonorHealth Scottsdale Shea Medical Center | Scottsdale | Arizona |
Lead Sponsor | Collaborator |
---|---|
HonorHealth Research Institute | Neolight |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in unconjugated bilirubin level from pre-test to post-test | heel stick blood draw for unconjugated bilirubin level | Assessment of the endpoint will occur at baseline, 12 hours following treatment, and 24 hours following initial treatment or prior to discharge. | |
Secondary | Maintain body temperature between 97.3F and 99.3F | monitor body temperature using a temperature monitoring device | Assessment of the endpoint will occur at baseline, 12 hours following treatment, and 24 hours following initial treatment or prior to discharge. | |
Secondary | Absence of skin irritation or ulceration | visual assessment of the skin for changes | Assessment of the endpoint will occur at baseline, 12 hours following treatment, and 24 hours following initial treatment or prior to discharge. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00735319 -
Transcutaneous Bilirubinometers in the Community
|
N/A | |
Completed |
NCT00114543 -
Trial of Aggressive Versus Conservative Phototherapy in Infants <1,000 Grams Birth Weight
|
Phase 3 | |
Withdrawn |
NCT04021927 -
Development of a Neonatal Jaundice Treatment Accelerator by Redirection of Unused Light During Phototherapy
|
N/A | |
Completed |
NCT01887327 -
Stannsoporfin With Light Therapy for Newborn Babies With Jaundice
|
Phase 2 | |
Completed |
NCT04632888 -
The Effect of Telephone Support for Breastfeeding Follow-up on Infantile Colic and Maternal Breastfeeding Self-efficacy
|
N/A | |
Not yet recruiting |
NCT04527536 -
Research of Diagnostic Value for BMJ Infants
|
||
Suspended |
NCT03741803 -
Relationship Between Delayed Cord Clamping at Birth and Neonatal Bilirubin Levels in Parturients With a Prior Child Requiring Therapy for Neonatal Jaundice
|
N/A | |
Completed |
NCT05650463 -
Evaluation of a Smartphone-based Screening Tool (Picterus Jaundice Pro) for Neonatal Jaundice in Dark Skin Newborns
|
N/A | |
Terminated |
NCT05623566 -
Evaluation of a Smartphone Based Screening Tool for Neonatal Jaundice in Surabaya, Indonesia
|
N/A | |
Completed |
NCT02612727 -
Filtered Sunlight Phototherapy to Treat Significant Jaundice: Safety and Efficacy in Neonates
|
N/A | |
Completed |
NCT01434810 -
Treatment of Neonatal Jaundice With Filtered Sunlight Phototherapy: Safety and Efficacy in African Neonates
|
N/A | |
Completed |
NCT03184948 -
Understanding Neonatal Jaundice in Rwanda
|
N/A | |
Completed |
NCT03942757 -
BiLirubin Decrease Under Phototherapy Exposure in the Preterm Newborn in Incubator
|
||
Not yet recruiting |
NCT05806684 -
Hyperbilirubinemia and Retinopathy of Prematurity in Preterm Infants: a Retrospective Study.
|
||
Completed |
NCT06372093 -
Evaluation of Bilirubin Measurements in Newborns From Smartphone Digital Images in a Population in Botswana
|
N/A | |
Completed |
NCT03570775 -
Effectiveness, Safety and Perceptions With the Use of One LED Sleeping Bag Device in the Treatment of Neonatal Jaundice
|
N/A | |
Completed |
NCT03569254 -
Effectiveness, Safety and Perceptions With the Use of One LED Blanket Device in the Ambulatory Treatment of Jaundice
|
N/A | |
Completed |
NCT05625880 -
Evaluation of Bilirubin Estimates in Newborns From Smartphone Digital Images in a Nepali Population
|
N/A | |
Completed |
NCT01169740 -
Transcutaneous Measurement of Jaundice in the Newborn
|
N/A | |
Not yet recruiting |
NCT06449508 -
The Effectiveness of Probiotics in Neonatal Jaundice
|
Phase 1/Phase 2 |